Skip to main content
Caplight Logo









The Organoid Company

The Organoid Company

Private
RotterdamHealthcare & Life Scienceshttps://theorganoidcompany.com/

Company Overview

The Organoid Company operates in Healthcare & Life Sciences and is based in Rotterdam. It was founded in 2024.

The Organoid Company is a biotechnology company that manufactures multi-lineage organoid models and provides digital biology tools for drug discovery and biological research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

The Organoid Company Comparables

Compare The Organoid Company with similar companies based on industry and business-model similarity.

The Organoid Company comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stem Pharm
82%
InSphero
79%
CELLphenomics GmbH
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

The Organoid Company Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for The Organoid Company. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Thomas Mitchell

CEO, Chairman, and Co-founder

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors grew 802% MoM, from 130 to 1.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

The Organoid Company Filings

Explore SEC and related filing metadata, where available.

The Organoid Company filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about The Organoid Company's valuation, stock price, and market status.

Is The Organoid Company a public or private company?

The Organoid Company is a private company.

What is the current stock price of The Organoid Company?

The Organoid Company is a private company, so its shares have no public market price. Caplight tracks The Organoid Company's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is The Organoid Company worth (valuation)?

Valuation information for The Organoid Company is not publicly available.

Can I buy The Organoid Company stock?

The Organoid Company shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was The Organoid Company's last funding round?

Funding round information for The Organoid Company is not publicly available.

Who are the main investors in The Organoid Company?

Investor information for The Organoid Company is not publicly disclosed.

Will The Organoid Company IPO soon?

No public IPO plans have been announced for The Organoid Company.

How can I track The Organoid Company secondary market activity?

Caplight tracks bids, offers, and trades in The Organoid Company's shares on secondary markets.

Firmographic Details

HeadquartersRotterdam
Employee Range2
Year Founded2024
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?